| 2/23/2011 | PP | Advanced Life Sciences arranges $5 million equity investment agreement
|
| 9/28/2010 | PP | Advanced Life Sciences seals $10 million equity distribution agreement
|
| 6/19/2009 | PP | New Issue: Advanced Life Sciences seals $15 million equity distribution agreement
|
| 4/8/2009 | CV | Advanced Life Sciences files $35 million shelf registration
|
| 10/23/2008 | PP | Market Commentary: Aquiline lands investor; Advanced Life ups loan; Potash One plans flow-through deal; Kodiak yanks offer
|
| 10/23/2008 | PP | New Issue: Advanced Life Sciences extends maturity date of line of credit, increases size to $10 million
|
| 10/3/2008 | PP | New Issue: Advanced Life Sciences arranges $15 million committed equity financing facility
|
| 12/12/2007 | PP | New Issue: Advanced Life Sciences plans $19.36 million stock placement
|
| 11/6/2006 | BT | Rodman starts Advanced Life at outperform
|
| 4/20/2006 | BT | Advanced Life Sciences gets $4 million revolver via Leaders Bank
|
| 2/28/2006 | BTPP | New Issue: Advanced Life Sciences Holdings secures $36 million from private placement of stock
|
| 2/28/2006 | BT | Market Commentary: Generex recoils along with most flu names; King Pharma clubbed; Elan, Biogen hit by analyst poll
|
| 2/28/2006 | PP | Market Commentary: Advanced Life Sciences prepares to close $36 million PIPE; Antares to settle $10.9 million offering
|
| 2/7/2006 | BT | Advanced Life Sciences awarded research grant to study drug against stroke
|
| 1/5/2006 | BT | Advanced Life Sciences begins phase 3 cethromycin trial
|
| 8/12/2005 | BT | Market Commentary: Electro-Optical seen pricing Tuesday; Coley, China Medical mixed; Alexion slips; Isis convertible bid up
|
| 8/5/2005 | BT | New Issue: Advanced Life sells upsized 6.4 million shares at $5 each, below cheapened range of $8-$9
|
| 8/5/2005 | BT | Market Commentary: Advanced Life Sciences IPO gets off at big price cut; AtriCure IPO bounces; Coley's IPO ahead
|
| 7/29/2005 | BT | Advanced Life Sciences IPO, lowered to $8-$9 per share from $11-$13, delayed
|
| 7/29/2005 | BT | Market Commentary: Advanced Life Sciences, Avalon IPOs delayed; ZymoGenetics on deck for Wed; stem cell names rise
|
| 7/28/2005 | BT | Market Commentary: Advanced Life Sciences IPO cut; ZymoGenetics plans follow-on; Elan plunges on credit worries
|
| 7/28/2005 | BT | Advanced Life Sciences lowers IPO price talk to $8 to $9 per share
|
| 7/27/2005 | BT | Market Commentary: Theravance rises; NPS Pharma off; Advanced Life Sciences IPO on for Thursday; Elan, Biogen slightly higher
|
| 7/25/2005 | BT | Market Commentary: Teva purchases Ivax, both higher; Endo Pharma climbs on possible sale of Ivax pain drug
|
| 7/22/2005 | BT | Market Commentary: Momenta gains at open, then goes south; Adams up against market; Durect convertibles up on buyback
|
| 7/7/2005 | BT | Market Commentary: Accentia delays IPO on positive news; Salix takes off; Millipore gains; Sepracor off; Amgen soars
|
| 7/6/2005 | BT | Market Commentary: Adams Respiratory sets IPO price; Accentia, Advanced Life Sciences seen on deck; Amgen issues higher
|
